The CCNE1 amplification identified in Patient #1′s tumor by FoundationOne next-generation sequencing is important in that it encodes the cyclin E1 protein (which regulates G1 to S phase transition) via binding to and activating cyclin-dependent protein kinase 2 (cdk2). The gene discussed is CDK2; the disease is neoplasm.